Sources of error in the retracted scientific literature

被引:53
作者
Casadevall, Arturo [1 ,2 ]
Steen, R. Grant [3 ]
Fang, Ferric C. [4 ,5 ]
机构
[1] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA
[2] Albert Einstein Coll Med, Div Infect Dis, Dept Med, Bronx, NY 10461 USA
[3] MediCC, Chapel Hill, NC USA
[4] Univ Washington, Sch Med, Dept Lab Med, Seattle, WA 98195 USA
[5] Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA
关键词
bibliometric analysis; biomedical publishing; ethics; HUMAN BASOPHIL DEGRANULATION; RESPONSIVE BREAST-CANCER; CONFER IMMUNE PRIVILEGE; GROUP; 1-98; TRIAL; CELL-LINES; CROSS-CONTAMINATION; CD95; LIGAND; MULTIDRUG-RESISTANCE; POSTMENOPAUSAL WOMEN; TAMOXIFEN RESPONSE;
D O I
10.1096/fj.14-256735
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Retraction of flawed articles is an important mechanism for correction of the scientific literature. We recently reported that the majority of retractions are associated with scientific misconduct. In the current study, we focused on the subset of retractions for which no misconduct was identified, in order to identify the major causes of error. Analysis of the retraction notices for 423 articles indexed in PubMed revealed that the most common causes of error-related retraction are laboratory errors, analytical errors, and irreproducible results. The most common laboratory errors are contamination and problems relating to molecular biology procedures (e.g., sequencing, cloning). Retractions due to contamination were more common in the past, whereas analytical errors are now increasing in frequency. A number of publications that have not been retracted despite being shown to contain significant errors suggest that barriers to retraction may impede correction of the literature. In particular, few cases of retraction due to cell line contamination were found despite recognition that this problem has affected numerous publications. An understanding of the errors leading to retraction can guide practices to improve laboratory research and the integrity of the scientific literature. Perhaps most important, our analysis has identified major problems in the mechanisms used to rectify the scientific literature and suggests a need for action by the scientific community to adopt protocols that ensure the integrity of the publication process.
引用
收藏
页码:3847 / 3855
页数:9
相关论文
共 80 条
[1]  
Alberts B, 2011, SCIENCE, V332, P1149, DOI 10.1126/science.332.6034.1149-a
[2]   Transgenic expression of CD95 ligand on islet beta cells induces a granulocytic infiltration but does not confer immune privilege upon islet allografts [J].
Allison, J ;
Georgiou, HM ;
Strasser, A ;
Vaux, DL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (08) :3943-3947
[3]  
[Anonymous], FORBES
[4]  
[Anonymous], 2014, NY TIMES
[5]  
[Anonymous], 2013, The Economist
[6]   Accuracy of data transfer: double data entry and estimating levels of error [J].
Atkinson, Ian .
JOURNAL OF CLINICAL NURSING, 2012, 21 (19-20) :2730-2735
[7]  
BAGENAL FS, 1990, LANCET, V336, P606
[8]   Recommendation of short tandem repeat profiling for authenticating human cell lines, stem cells, and tissues [J].
Barallon, Rita ;
Bauer, Steven R. ;
Butler, John ;
Capes-Davis, Amanda ;
Dirks, Wilhelm G. ;
Elmore, Eugene ;
Furtado, Manohar ;
Kline, Margaret C. ;
Kohara, Arihiro ;
Los, Georgyi V. ;
MacLeod, Roderick A. F. ;
Masters, John R. W. ;
Nardone, Mark ;
Nardone, Roland M. ;
Nims, Raymond W. ;
Price, Paul J. ;
Reid, Yvonne A. ;
Shewale, Jaiprakash ;
Sykes, Gregory ;
Steuer, Anton F. ;
Storts, Douglas R. ;
Thomson, Jim ;
Taraporewala, Zenobia ;
Alston-Roberts, Christine ;
Kerrigan, Liz .
IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, 2010, 46 (09) :727-732
[9]   Raise standards for preclinical cancer research [J].
Begley, C. Glenn ;
Ellis, Lee M. .
NATURE, 2012, 483 (7391) :531-533
[10]   A ROLE FOR CD95 LIGAND IN PREVENTING GRAFT-REJECTION [J].
BELLGRAU, D ;
GOLD, D ;
SELAWRY, H ;
MOORE, J ;
FRANZUSOFF, A ;
DUKE, RC .
NATURE, 1995, 377 (6550) :630-632